Literature DB >> 11269654

Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.

H Liu1, J Dan, S Tang, S Wu.   

Abstract

The chimeric receptors were prepared by exchanging the cytoplasmic region between leukemia inhibitory factor (LIF) receptor alpha subunit (gp190) and the other subunit-gp130 (190/130,130/190) and separately transduced into leukemia line HL-60 (to have the wild type subunit). The purpose is to investigate which subunit for activating MAPK p42/44 in leukemia cell while the cytoplasmic region homodimerization (190cyt-190cyt, 130cyt-130cyt) was induced by LIF. The results showed that MAPK p42/44 expression level after LIF stimulation 5 h was lower in the transformants with pED 130/190 (190cyt- 190cyt) (p < 0.01) and higher in the transformants with pED 190/130 (130cyt- 130cyt) (p < 0.05) than those in the parent cells. Meanwhile, MAPK p42/44 phosphorylation (Thr202/Tyr204) was ascended and the highest at 10 min in the 190/130 and descended in the 130/190. It suggests that gp130 activate MAPK p42/44 and gp190 indirectly regulate its expression and function. In order to analyses the relation of the subunit oligomerization and MAPK p42/44 we also prepared the recombination of the extracellular and transmembrane region of Fas and the cytoplasmic region of each LIFR subunit (Fas/190, Fas/130). After transduction into HL-60 with lipofection and induction by anti-Fas IgG, we found that MAPK p42/44 expression levels were lower in the Fas/190 than in the Fas/130 and parent cells (p < 0.01) and no difference between the Fas/130 and the wild type receptor. However, phospho-MAPK p42/44 were increased in the Fas/130 than the parent cells. It suggests that the oligomerization of the cytoplasmic regions of gp130 be potential to normally initiate MAPK p42/44 for the signal of HL-60 proliferation. We also determine that the separated oligomerization FasDD (no dimerization) can initiate the corresponding signal molecules, then regulate MAPK p42/44 expression and phosphorylation in leukemia cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269654     DOI: 10.1023/a:1007220627845

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

Authors:  D P Gearing; M R Comeau; D J Friend; S D Gimpel; C J Thut; J McGourty; K K Brasher; J A King; S Gillis; B Mosley
Journal:  Science       Date:  1992-03-13       Impact factor: 47.728

2.  FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Authors:  A M Chinnaiyan; K O'Rourke; M Tewari; V M Dixit
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

3.  A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain.

Authors:  M P Boldin; E E Varfolomeev; Z Pancer; I L Mett; J H Camonis; D Wallach
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

4.  Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha- and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras.

Authors:  W P Schiemann; J L Bartoe; N M Nathanson
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

Review 5.  Tumor necrosis factor receptor and Fas signaling mechanisms.

Authors:  D Wallach; E E Varfolomeev; N L Malinin; Y V Goltsev; A V Kovalenko; M P Boldin
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

Authors:  J N Lavoie; G L'Allemain; A Brunet; R Müller; J Pouysségur
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

7.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

8.  Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells.

Authors:  H Baumann; S F Ziegler; B Mosley; K K Morella; S Pajovic; D P Gearing
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

9.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

Authors:  N Stahl; T G Boulton; T Farruggella; N Y Ip; S Davis; B A Witthuhn; F W Quelle; O Silvennoinen; G Barbieri; S Pellegrini
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

10.  Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.

Authors:  Y Yamanaka; K Nakajima; T Fukada; M Hibi; T Hirano
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

View more
  2 in total

1.  Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.

Authors:  Houqi Liu; Shanrong Liu; Shuping Tang; Kaihong Ji; Fengmei Wang; Shijie Hu
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

2.  Secretory TAT-peptide-mediated protein transduction of LIF receptor α-chain distal cytoplasmic motifs into human myeloid HL-60 cells.

Authors:  Q Sun; J Xiong; J Lu; S Xu; Y Li; X P Zhong; G K Gao; H Q Liu
Journal:  Braz J Med Biol Res       Date:  2012-06-21       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.